Investors are being urged to quickly sell off any stock they have in pharmaceutical giant and Covid mRNA shot maker Moderna.
Investment experts are advising investors to “get your money out” of Moderna before August 1.
Moderna, which uses a spin on “mRNA” for its name, only sells one product – Covid injections.
The company is among three biotech firms that investors are being advised to dump stock in.
The news is leading to speculation as to why the once high-flying, COVID-19 vaccine maker Moderna is one of those equities that needs to be sold by the end of July.
The three companies that are on the investors’ chopping block are:
- Moderna (mRNA)
- Cassava (SAVA)
- Ardelyx (ARDX)
Investor Place’s Mohammed Saqib reminds all of the volatile nature of biotech stocks, fluctuations, risks, and the like.
With stock prices contingent on key data from a blinded clinical trial involving some novel advancement studies, mere press releases can trigger biotech stock price swings.
Pointing to Precedence Research, global biotechnology markets are projected to grow from $1.38 trillion in 2023 to approximately $4.25 trillion by 2033.
Saqib at InvestorPlace informs that this expected growth is largely to be driven by advancements in various biotechnological fields.
Those advancements are in areas including bio-pharmacy, bio-industries, bio-services, and bioinformatics.
In a report from InvestorPlace, Saqib’s concerns about Moderna’s future.
Post the “meteoric rise during the COVID-19 pandemic,” the InvestorPlace article points to the “volatile waters” faced by the company.
This volatility is “largely due to unsustainable revenue growth and mounting competitive pressures,” he notes.
Pointing to mRNA-based competition, the analyst provides Pfizer/BioNTech as an example, yet doesn’t discuss other mRNA-based products.
Saqib also notes the rise of protein-based vaccines (think of Sanofi $1+ billion dela Novavax).
Protein-based vaccines have proved to be far more successful in study results than mRNA shots in some head-to-head investigational battles.
Of course, there is the near complete collapse of the company’s finances, when looking at the whole situation comprehensively, and with keen objectivity.
With an apex of revenue at $19.26 billion in 2022, a complete collapse ensued in 2023–to $6.84 billion.
The InvestorPlace opinion piece then points out that in Q1 2024, revenue plummeted to $167 million.
This revenue plunge was “a staggering 91% drop from the same period last year. “
Calling this a “troubling trajectory” based on “deep-rooted issues in product demand and market saturation” plus diminishing urgency associated with Covid shots all makes sense.
What isn’t discussed, the elephant in the room, is the technology platform itself, volatility, and immaturity that could still get someone censored on some social media (signaling a bigger problem in our economy and society).
In addition, Moderna is now completely dependent on an absolute home run with its ongoing melanoma and lung cancer clinical trials.
Meanwhile, Moderna is still facing a growing backlash against its Covid mRNA vaccines.
An increasing number of studies now show Moderna’s mRNA injections have deadly side effects.
As Slay News recently reported, official data from the U.S. Centers for Disease Control and Prevention (CDC) shows that Moderna’s Covid mRNA injections are even more deadly than Pfizer’s equivalent offering.
According to the CDC’s Vaccine Adverse Event Reporting System (VAERS), Moderna’s shot causes 30 percent more deaths per dose than Pfizer’s.
VAERS is a database that accepts reports of adverse events that occur following vaccination.
Reports are submitted to VAERS by doctors, healthcare providers, vaccine manufacturers, and other medical professionals.
A study using data from VAERS was conducted by MIT computer scientist the inventor of the optical computer mouse Steve Kirsch.
Kirsch, the founder of the Vaccine Safety Research Foundation (VSRF), asserts that he is now able to “prove beyond any reasonable doubt that the Covid vaccines caused unacceptable increases in all-cause mortality for those who opted for the shots.”
According to Kirsch, his study found that “the VAERS data clearly shows that the Moderna vaccine causes a disproportionately higher number of deaths than Pfizer.”
However, he notes that this was always known “but the medical community chose to ignore it.”
